Skip to Content
You are currently on the new version of our website. Access the old version .
CancersCancers
  • Article
  • Open Access

12 December 2022

14 Pages

Prospective Investigation of 18FDG-PET/MRI with Intravoxel Incoherent Motion Diffusion-Weighted Imaging to Assess Survival in Patients with Oropharyngeal or Hypopharyngeal Carcinoma

,
,
,
,
,
,
,
and
1
Department of Nuclear Medicine, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 970423, Taiwan
2
School of Medicine, Tzu Chi University, Hualien 970423, Taiwan
3
Department of Diagnostic Radiology, Linkou Chang Gung Memorial Hospital and Chang Gung University, Taoyuan 333423, Taiwan
4
Department of Radiation Oncology, Linkou Chang Gung Memorial Hospital and Chang Gung University, Taoyuan 333423, Taiwan
This article belongs to the Section Cancer Biomarkers

Simple Summary

Intravoxel incoherent motion (IVIM) diffusion-weighted imaging (DWI) is an advanced MRI technique from which both diffusion and perfusion parameters of tumor tissues can be extracted. The question as to whether 18F-FDG PET/MRI using the IVIM-DWI technique may provide prognostic information in patients with head-and-neck cancers remains unanswered. This prospective study was therefore designed to evaluate the prognostic significance of IVIM, dynamic contrast-enhanced MRI (DCE-MRI), and PET parameters derived from integrated PET/MRI in patients with oropharyngeal or hypopharyngeal squamous cell carcinomas (OHSCC). Our results indicated that metabolic tumor volume on 18F-FDG PET and D* derived from IVIM-DWI were independent risk factors for overall survival, whereas Ktrans and iAUC derived from DCE-MRI were significant predictors of recurrence-free survival. Combining PET/MRI biomarkers with clinical risk factors aided in formulating prognostic models, which demonstrated higher accuracy in predicting overall or recurrence-free survival over the traditional TNM staging system.

Abstract

To prospectively investigate the prognostic value of 18F-FDG PET/MRI in patients with oropharyngeal or hypopharyngeal squamous cell carcinomas (OHSCC) treated by chemoradiotherapy. The study cohort consisted of patients with OHSCC who had undergone integrated PET/MRI prior to chemoradiotherapy or radiotherapy. Imaging parameters derived from intravoxel incoherent motion (IVIM), dynamic contrast-enhanced MRI (DCE-MRI), and 18F-FDG PET were analyzed in relation to overall survival (OS) and recurrence-free survival (RFS). In multivariable analysis, T classification (p < 0.001), metabolic tumor volume (p = 0.013), and pseudo-diffusion coefficient (p = 0.008) were identified as independent risk factors for OS. The volume transfer rate constant (p = 0.015), initial area under the curve (p = 0.043), T classification (p = 0.018), and N classification (p = 0.018) were significant predictors for RFS. The Harrell’s c-indices of OS and RFS obtained from prognostic models incorporating clinical and PET/MRI predictors were significantly higher than those derived from the traditional TNM staging system (p = 0.001). The combination of clinical risk factors with functional parameters derived from IVIM and DCE-MRI plus metabolic PET parameters derived from 18F-FDG PET in integrated PET/MRI outperformed the information provided by traditional TNM staging in predicting the survival of patients with OHSCC.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.